Med sales in Egypt increased by 25% to EGP 50 bn in 2016, Federation of Egyptian Chambers of Commerce’s pharma division chief Ali Auf said on Saturday, Al Mal reports. Recent government-sanctioned price hikes to meds are being credited with the jump in sales and are expected to drive further growth in sales this year to around EGP 65 bn, according to Auf.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…